NCT00042445
- Conditions
- Brain Diseases, Brain Neoplasm, Brain Neoplasms, +10 more
- Locations
-
- Harvard School of Public Health Boston, Massachusetts, United States
- Kaohsiung Medical University Kaohsiung City, Taiwan
Clinical trial condition
Leukemia
Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.
1,710 public trials
183 recruiting studies
Leukemia trial results
NCT00082303
- Conditions
- Anxiety Disorders, Behavior, Behavioral Symptoms, +13 more
- Locations
-
- Indiana University Cancer Center/University Hospital Indianapolis, Indiana, United States
Completed
Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell Transplant
NCT00044733
- Conditions
- Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Little Rock, Arkansas, United States
- Hartford, Connecticut, United States
- Jacksonville, Florida, United States
- Honolulu, Hawaii, United States
Completed
Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas
NCT00035022
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- M.D. Anderson Cancer Center Houston, Texas, United States
Completed
Study Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of CML in Chronic Phase
NCT00027144
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
- Locations
-
- University of Connecticut Health Center Farmington, Connecticut, United States
NCT00005892
- Conditions
- Anemia, Anemia, Aplastic, Anemia, Hypoplastic, Congenital, +33 more
- Locations
-
- Fairview University Medical Center Minneapolis, Minnesota, United States
Completed
Protection Against Benzene Toxicity
NCT00011453
- Conditions
- Anemia, Anemia, Aplastic, Aplastic Anemia, +7 more
- Locations
-
- University of Colorado Health Sciences Center Denver, Colorado, United States
NCT05886491
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
- Locations
-
- University of Alabama at Birmingham (UAB) Hospital Birmingham, Alabama, United States
- City of Hope Duarte, California, United States
- Sarah Cannon/CBCI Denver, Colorado, United States
- Comprehensive Cancer Center of Northwestern University Chicago, Illinois, United States
Terminated
GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL
NCT04601584
- Conditions
- ALL, B-precursor Acute Lymphoblastic Leukemia, GNR-084, +14 more
- Locations
-
- Federal State Budget Funded Institution National Medical Research Center of Hematology, Ministry of Health of the Russian Federation (MoH of Russia) Moscow, Russia
- Almazov National Medical Research Centre Saint Petersburg, Russia
- Pavlov First Saint Petersburg State Medical University Saint Petersburg, Russia
Terminated
A Safety and Efficacy Study of CD-19 t-haNK in Patients With B-cell Acute Lymphoblastic Leukemia
NCT07556757
- Conditions
- B-ALL, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- Dr Jackie Thomson Inc Johannesburg, South Africa
- Alberts Cellular Therapy Pretoria, South Africa